Exane Derivatives’s Fortuna Silver Mines FSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$434 Hold
153
﹤0.01% 588
2022
Q1
$583 Hold
153
﹤0.01% 845
2021
Q4
$597 Hold
153
﹤0.01% 752
2021
Q3
$601 Sell
153
-2,889
-95% -$12.9K ﹤0.01% 922
2021
Q2
$15.8K Buy
+3,042
New +$20.1K ﹤0.01% 728
2020
Q4
Sell
-7,700
Closed -$48.7K 844
2020
Q3
$48.7K Hold
7,700
0.01% 375
2020
Q2
$38.8K Hold
7,700
0.01% 372
2020
Q1
$17.5K Hold
7,700
﹤0.01% 411
2019
Q4
$30K Hold
7,700
0.01% 382
2019
Q3
$23.8K Hold
7,700
﹤0.01% 394
2019
Q2
$21.9K Hold
7,700
﹤0.01% 423
2019
Q1
$25.7K Sell
7,700
-15,300
-67% -$56.6K 0.01% 369
2018
Q4
$84.4K Hold
23,000
0.02% 332
2018
Q3
$99.7K Hold
23,000
0.02% 318
2018
Q2
$130K Hold
23,000
0.02% 305
2018
Q1
$119K Hold
23,000
0.02% 280
2017
Q4
$120K Hold
23,000
0.02% 274
2017
Q3
$101K Hold
23,000
0.02% 255
2017
Q2
$113K Buy
23,000
+17,000
+283% +$81.6K 0.02% 262
2017
Q1
$29.3K Buy
+6,000
New +$35.4K 0.01% 304

Other funds holding FSM

Exane Derivatives's FSM Position: Q2 2022 in Review

Exane Derivatives held its Fortuna Silver Mines (FSM) position steady in Q2 2022 at 153 shares worth $434. The position accounts for ﹤0.01% of the portfolio, ranked #588.

Exane Derivatives first reported a position in FSM in Q1 2017 and has held it in 20 quarters since. The position peaked at $130K in Q2 2018. 128 funds tracked by Wall St. Rank hold FSM as of Q2 2022.

  • Exane Derivatives held 153 shares of Fortuna Silver Mines worth $434 as of Q2 2022.
  • Exane Derivatives left its Fortuna Silver Mines share count unchanged in Q2 2022.
  • Fortuna Silver Mines made up ﹤0.01% of Exane Derivatives's portfolio in Q2 2022, its #588 holding.
  • Exane Derivatives first reported a position in Fortuna Silver Mines in Q1 2017 and has held it in 20 quarters since.
  • Exane Derivatives's Fortuna Silver Mines position peaked at $130K in Q2 2018.
  • 128 funds tracked by Wall St. Rank held Fortuna Silver Mines as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.